350 related articles for article (PubMed ID: 31136735)
1. Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases.
Mehta M; Deeksha ; Tewari D; Gupta G; Awasthi R; Singh H; Pandey P; Chellappan DK; Wadhwa R; Collet T; Hansbro PM; Kumar SR; Thangavelu L; Negi P; Dua K; Satija S
Chem Biol Interact; 2019 Aug; 308():206-215. PubMed ID: 31136735
[TBL] [Abstract][Full Text] [Related]
2. Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases.
Liao W; Dong J; Peh HY; Tan LH; Lim KS; Li L; Wong WF
Molecules; 2017 Jan; 22(1):. PubMed ID: 28106744
[TBL] [Abstract][Full Text] [Related]
3. Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation.
Sun Y; Zhao Y; Zhao X; Lee RJ; Teng L; Zhou C
Molecules; 2017 Oct; 22(10):. PubMed ID: 29027965
[TBL] [Abstract][Full Text] [Related]
4. Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
Chistiakov DA; Sobenin IA; Orekhov AN
Drug Deliv; 2012 Nov; 19(8):392-405. PubMed ID: 23173580
[TBL] [Abstract][Full Text] [Related]
5. miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents.
Baumann V; Winkler J
Future Med Chem; 2014; 6(17):1967-84. PubMed ID: 25495987
[TBL] [Abstract][Full Text] [Related]
6. Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease.
Séguin RM; Ferrari N
Expert Opin Investig Drugs; 2009 Oct; 18(10):1505-17. PubMed ID: 19715448
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic oligonucleotides.
Goodchild J
Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
[TBL] [Abstract][Full Text] [Related]
8. RNA-targeted therapeutics in cancer clinical trials: Current status and future directions.
Barata P; Sood AK; Hong DS
Cancer Treat Rev; 2016 Nov; 50():35-47. PubMed ID: 27612280
[TBL] [Abstract][Full Text] [Related]
9. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
[TBL] [Abstract][Full Text] [Related]
10. Emerging trends in the novel drug delivery approaches for the treatment of lung cancer.
Sharma P; Mehta M; Dhanjal DS; Kaur S; Gupta G; Singh H; Thangavelu L; Rajeshkumar S; Tambuwala M; Bakshi HA; Chellappan DK; Dua K; Satija S
Chem Biol Interact; 2019 Aug; 309():108720. PubMed ID: 31226287
[TBL] [Abstract][Full Text] [Related]
11. Safety of antisense oligonucleotide and siRNA-based therapeutics.
Chi X; Gatti P; Papoian T
Drug Discov Today; 2017 May; 22(5):823-833. PubMed ID: 28159625
[TBL] [Abstract][Full Text] [Related]
12. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
13. From Genesis to Revelation: The Role of Inflammatory Mediators in Chronic Respiratory Diseases and their Control by Nucleic Acid-based Drugs.
Gioia SD; Sardo C; Castellani S; Porsio B; Belgiovine G; Carbone A; Giammona G; Cavallaro G; Conese M
Curr Drug Deliv; 2017; 14(2):253-271. PubMed ID: 27557670
[TBL] [Abstract][Full Text] [Related]
14. Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications.
Benizri S; Gissot A; Martin A; Vialet B; Grinstaff MW; Barthélémy P
Bioconjug Chem; 2019 Feb; 30(2):366-383. PubMed ID: 30608140
[TBL] [Abstract][Full Text] [Related]
15. Recent advances of siRNA delivery by nanoparticles.
Yuan X; Naguib S; Wu Z
Expert Opin Drug Deliv; 2011 Apr; 8(4):521-36. PubMed ID: 21413903
[TBL] [Abstract][Full Text] [Related]
16. Nucleic acid-based therapeutics for dermal wound healing.
Sharma P; Kumar A; Agarwal T; Dey AD; Moghaddam FD; Rahimmanesh I; Ghovvati M; Yousefiasl S; Borzacchiello A; Mohammadi A; Yella VR; Moradi O; Sharifi E
Int J Biol Macromol; 2022 Nov; 220():920-933. PubMed ID: 35987365
[TBL] [Abstract][Full Text] [Related]
17. Dendrimer Nanovectors for SiRNA Delivery.
Liu X; Peng L
Methods Mol Biol; 2016; 1364():127-42. PubMed ID: 26472447
[TBL] [Abstract][Full Text] [Related]
18. Oligonucleotide-Based Therapeutics: An Emerging Strategy for the Treatment of Chronic Liver Diseases.
Alkhouri N; Reddy GK; Lawitz E
Hepatology; 2021 Apr; 73(4):1581-1593. PubMed ID: 32978989
[No Abstract] [Full Text] [Related]
19. A Comprehensive Review on Role of Nanoparticles in Therapeutic Delivery of Medicine.
Rathor S; Bhatt DC; Aamir S; Singh SK; Kumar V
Pharm Nanotechnol; 2017; 5(4):263-275. PubMed ID: 29141578
[TBL] [Abstract][Full Text] [Related]
20. Click conjugated polymeric immuno-nanoparticles for targeted siRNA and antisense oligonucleotide delivery.
Chan DP; Deleavey GF; Owen SC; Damha MJ; Shoichet MS
Biomaterials; 2013 Nov; 34(33):8408-15. PubMed ID: 23932248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]